BullishMEDIUM severityEarnings56d ago

InnovAge forecasts $1.05B-$1.085B revenue and $105M-$115M adjusted EBITDA for fiscal 2027 as it targets 5%-7.5% census growth

InnovAge forecasts $1.05B-$1.085B revenue and $105M-$115M adjusted EBITDA for fiscal 2027 as it targets 5%-7.5% census growth — $INNV one-month chart
$INNV daily closes over the past month · Wook of Wall Street artwork from market data
WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.

Wook analysis

What it means

Key points
  • What to watch: This one turns on a concrete figure (5%); set it against the recent trend before reading it as a turning point.
  • How the stock is trading: $INNV -0.78% in the latest session.
  • Timing: It arrived overnight — the change beside it belongs to a session that had already packed up and gone home. Market holidays are not detected.
Amount$1.05 billion
Amount$1.085 billion
Amount$105 million
Amount$115 million

Where the stock stands

$INNV last traded at $8.85, -0.78% on the session. That puts it 30% shy of its 52-week high of $12.64 and 125% clear of its low of $3.94 — a little above the middle of the range. Over the year it has ranged 221% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $INNV page.

How much coverage it is getting

This is the only story Wook has logged on $INNV in the last 30 days — a quiet name that just got a headline. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.

The bigger picture

Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.

What to watch next

For the receipts, the $INNV page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $INNV is from its high, or how this week's coverage compares.

How this analysis was made

Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “growth” in the wording, with nothing on the bearish side to offset it. It was matched to $INNV. It carried $1.05 billion, $1.085 billion, $105 million and $115 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.

The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on September 9, 2026. $INNV has moved -19.76% ($11.03 to $8.85). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.